12/15/2025
Texas A&M researcher Dr. Praveen Rajendran secures $1.32M from NCI PREVENT to study low-dose drug combinations targeting colitis-associated colorectal cancer, in collaboration with Drs. Dashwood (Texas A&M) & Vilar-Sanchez (MD Anderson).
To advance knowledge and technology in bioscience and the health professions through innovative rese IBT students pursue a Ph.D.
2121 W. Holcombe Boulevard
Houston, TX
77030
| Monday | 8am - 5pm |
| Tuesday | 8am - 5pm |
| Wednesday | 8am - 5pm |
| Thursday | 8am - 5pm |
| Friday | 8am - 5pm |
Be the first to know and let us send you an email when Texas A&M Institute of Biosciences and Technology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.